Title 16, HEALTH

Sec. 4.6. As used in this chapter, "mortuary" means a funeral home (as defined in IC 25-15-2-15). As added by P.L.96-2026, SEC.29.

Sec. 5. As used in this chapter, "pathological waste" includes: (1) tissues; (2) organs; (3) body parts; and (4) blood or body fluids in liquid or semiliquid form; that are removed during surgery, biopsy, or autopsy. The term does not include an aborted fetus or a miscarried fetu…

Sec. 6. As used in this chapter, "secure area" means an area that is designed and maintained to prevent the entry of unauthorized persons. [Pre-1993 Recodification Citation: 16-1-9.7-5.] As added by P.L.2-1993, SEC.24.

Sec. 6.6. As used in this chapter, "waste handler" means a person who handles infectious waste. As added by P.L.96-2026, SEC.30.

Sec. 6.9. (a) A person who generates infectious waste is responsible for the: (1) appropriate containment; (2) appropriate labeling; (3) effective treatment; (4) transport; and (5) disposal of; infectious waste as required by this chapter. (b) A person may provide services to the…

Sec. 7. (a) Before infectious waste is placed in an area that is not a secure area and before the waste is sent for final disposal, a person shall: (1) conduct effective treatment on the infectious waste on site; or (2) transport the infectious waste off site for effective treatm…

Sec. 7.5. Any waste that is not infectious waste (as defined in section 4(c) of this chapter) must be double bagged and tied to protect handlers. As added by P.L.146-1996, SEC.7.

Sec. 7.6. (a) This section applies to a person or facility possessing either an aborted fetus or a miscarried fetus. (b) Within ten (10) business days after a miscarriage occurs or an abortion is performed, a person or facility described in subsection (a) shall: (1) conduct the f…

Sec. 7.7. (a) A person shall ensure that infectious waste is, at all times, contained in a manner that will reasonably protect: (1) a waste handler; and (2) the public; from contracting a dangerous communicable disease that may result from exposure to the infectious waste. (b) A …

Sec. 7.8. A person shall have written policies and procedures that include at least the following: (1) The requirements of this chapter. (2) The sanctions for failing to comply with the requirements of this chapter, including the discipline and dismissal of a person. (3) The inst…

Sec. 7.9. (a) If infectious waste is stored before final disposal, a person shall do the following: (1) Store the infectious waste in a secure area that: (A) is locked or otherwise secured to eliminate access by or exposure to the public; (B) affords protection from adverse envir…

Sec. 8. (a) After consulting with an advisory committee composed of representatives of persons or facilities that handle infectious wastes, the state department may adopt rules under IC 4-22-2 necessary to carry out this chapter. (b) The state department may adopt rules under thi…

Sec. 8.5. (a) A person shall: (1) transport infectious waste in a manner that reasonably protects waste handlers and the public from contracting a dangerous communicable disease; and (2) before the infectious waste in compacted, conduct effective treatment of the infectious waste…

Sec. 9. (a) The state department may designate an agent who may enter on private property to inspect for and investigate possible violations of this chapter or rules adopted under this chapter if the following conditions are met: (1) The agent has probable cause to believe that e…

Sec. 1. (a) The state department shall develop a strategic plan to identify and significantly reduce the prevalence of diabetes and prediabetes in Indiana. (b) In developing the strategic plan under subsection (a), the state department shall collaborate with the office of the sec…

Sec. 2. In developing and updating the strategic plan under section 1 of this chapter, the workgroups established under section 1(c) of this chapter shall do the following: (1) Establish baseline benchmarks for diabetes and prediabetes in Indiana using Indiana specific data. (2) …

Sec. 3. Before December 31, 2019, the state department shall deliver a written report to the governor and, in an electronic format under IC 5-14-6, to the general assembly that includes: (1) the strategic plan developed under section 1 of this chapter; and (2) recommendations on …

Sec. 4. This chapter expires July 1, 2026. As added by P.L.33-2018, SEC.1.

Sec. 0.3. (a) As used in this chapter, "de-identified maximum negotiated charge" means the highest charge that a hospital or an ambulatory outpatient surgical center has negotiated with any third party payer for an item or service. (b) As used in this chapter, "de-identified mini…

Sec. 1. (a) Not later than December 31, 2025, a hospital and an ambulatory outpatient surgical center shall post on the website of the hospital or ambulatory outpatient surgical center pricing and other information specified in this chapter for the following: (1) For as many of t…

Sec. 2. (a) The information displayed on the website must be in an easy to read, understandable format, and include the standard charges as described in section 1 of this chapter for each service. (b) An ambulatory outpatient surgical center shall update the information on the we…

Sec. 0.5. This chapter does not apply when an individual is detained or committed under IC 12-26-5, IC 12-26-6, or IC 12-26-7. As added by P.L.16-2004, SEC.3. Amended by P.L.205-2023, SEC.22.

Sec. 1. As used in this chapter, "psychiatric advance directive" means a written instrument that expresses the individual's preference and consent to the administration of treatment measures for a specific diagnosis for the care and treatment of the individual's mental illness du…

Sec. 2. (a) An individual who has capacity may execute a psychiatric advance directive. (b) The psychiatric advance directive must include the following: (1) The name of the individual entering into the psychiatric advance directive. (2) The name of the treatment program and the …

Sec. 3. An individual may specify in the psychiatric advance directive treatment measures, including: (1) admission to an inpatient setting; (2) the administration of prescribed medication: (A) orally; or (B) by injection; (3) physical restraint; (4) seclusion; (5) electroconvuls…

Sec. 4. A person who: (1) treats an individual who has executed a psychiatric advance directive; and (2) is not aware that the individual being treated has executed a valid psychiatric advance directive; is not subject to civil or criminal liability based on an allegation that th…

Sec. 5. This chapter does not preclude an attending physician from treating the patient in a manner that is of the best interest of the patient or another individual. As added by P.L.16-2004, SEC.3.

Sec. 1. As used in this chapter, "waste blood specimen" means a blood sample or a solid, liquid, or semiliquid blood product that: (1) has served the intended purpose under section 4 of this chapter; or (2) has served the natural, biological, medical, or intended purpose and has …

Sec. 10. (a) The state department shall develop the following: (1) A registry for tracking and follow-up of all newborns and individuals for screening. (2) A centralized program that provides follow-up, diagnosis, management, and family counseling and support, including equipment…

Sec. 11. (a) The newborn screening fund is established for the purpose of carrying out this chapter. The state department shall administer the fund. (b) The expenses of the newborn screening program shall be paid from money in the fund. (c) Money in the fund at the end of a state…

Sec. 2. (a) Subject to subsection (d), every infant shall be given examinations at the earliest feasible time for the detection of the following disorders: (1) Phenylketonuria. (2) Hypothyroidism. (3) Hemoglobinopathies, including sickle cell anemia. (4) Galactosemia. (5) Maple S…

Sec. 3. The state department shall conduct an intensive educational program among physicians, hospitals, public health nurses, and the public concerning the disorders listed in section 2 of this chapter. The educational program must include information about: (1) the nature of th…

Sec. 4. After consultation with medical authorities, the state department shall require appropriate tests to be used in the detection of disorders listed in section 2 of this chapter. [Pre-1993 Recodification Citation: 16-8-6-3.] As added by P.L.2-1993, SEC.24.

Sec. 5. The state department and all local boards of health shall encourage and promote the development of plans and procedures for the detection of the disorders listed in section 2 of this chapter in all local health jurisdictions of Indiana. [Pre-1993 Recodification Citation: …

Sec. 6. (a) The state department shall provide forms on which the results of tests performed on each child for the disorders listed in section 2 of this chapter shall be reported to the state department by physicians and hospitals. (b) The state department shall ascertain at leas…

Sec. 7. (a) The state department shall designate at least one (1) laboratory for testing for disorders listed in section 2(a) of this chapter. (b) The designated laboratories shall perform tests on all infants for the detection of disorders under section 2(a) of this chapter. (c)…

Sec. 8. (a) Each hospital and physician shall: (1) subject to subsection (b), take or cause to be taken a blood sample from every infant born under the hospital's and physician's care; and (2) transport or cause to be transported each blood sample described in subdivision (1) to …

Sec. 9. The state department shall adopt rules under IC 4-22-2 to carry out this chapter, including rules to ensure the following: (1) Proper and timely sample collection and transportation under section 8 of this chapter. (2) Quality testing procedures at the laboratories design…

Sec. 1. Notwithstanding any rule or regulation adopted by the federal Food and Drug Administration concerning sodium saccharin, N.F., the chemical substance sodium saccharin, N.F. may be manufactured, distributed, sold, and used within Indiana. [Pre-1993 Recodification Citation: …

Sec. 2. (a) The Indiana board of pharmacy and the state department may not prohibit the manufacture, distribution, sale, or use of sodium saccharin, N.F. within Indiana, either as a component of any other substance produced within Indiana or as a separate product. (b) The state d…

Sec. 3. A person who is engaged in the manufacture, sale, distribution, or use of sodium saccharin, N.F. may not be prohibited from the manufacture, sale, distribution, or use of sodium saccharin, N.F. within Indiana. [Pre-1993 Recodification Citation: 16-8-9-3.] As added by P.L.…

Sec. 1. As used in this chapter, "council" refers to the rare disease advisory council established by section 2 of this chapter. As added by P.L.129-2023, SEC.2.

Sec. 10. Eight (8) members of the council constitute a quorum. The affirmative vote of a majority of the quorum is required for the council to take any action. As added by P.L.129-2023, SEC.2.

Sec. 11. (a) Each member of the council who is not a state employee is entitled to receive both of the following: (1) The minimum salary per diem provided by IC 4-10-11-2.1(b). (2) Reimbursement for travel expenses and other expenses actually incurred in connection with the membe…

Sec. 12. The state department shall provide administrative assistance to and pay the administrative expenses of the council. As added by P.L.129-2023, SEC.2.

Sec. 13. (a) Beginning January 1, 2024, the council shall submit an annual report to the governor and the legislative council not later than June 15. The report submitted to the legislative council must be in an electronic format under IC 5-14-6. (b) The report required in subsec…